eGenesis
Phase 1/2At eGenesis, we envision a world where transplantation is accessible to all. We develop safe and effective human-compatible organs for transplantation.
Founded
2015
Focus
BiologicsCell & Gene Therapy
About
At eGenesis, we envision a world where transplantation is accessible to all. We develop safe and effective human-compatible organs for transplantation.
Funding History
3Total raised: $288M
Series C$125MLeaps by BayerJun 15, 2023
Series B$125MFresenius Medical Care VenturesMar 15, 2021
Series A$38MARCH Venture PartnersSep 15, 2017
Company Info
TypePrivate
Founded2015
LocationCambridge, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile